| abstract |
Disclosed is a composition and / or method of treatment for cancer that utilizes synergistic effects found in therapeutic combinations that can reduce and / or eliminate the side effects associated with conventional treatments. Measuring the level of protein lysine acetylation before application of the combination therapy of entinostat-aromatase inhibitor, applying the combination therapy, measuring the level of protein lysine acetylation after application of the combination therapy, When the level of protein lysine acetylation after application of the combination therapy is compared with the level before application of the combination therapy, and the level of protein lysine acetylation after application of the combination therapy is greater than the level before application of the combination therapy, A method of continuing treatment with combination therapy. A method in which the change in protein lysine acetylation level is measured on each of 2, 5, 7, 15, 21 days of treatment. [Selection] Figure 1 |